文献速递胃肠外科围术期管理与 ERAS

微创食管切除术能否替代开放食管切除术治疗食管癌?日本国家临床数据库24,233例食管切除术最新分析

Can Minimally Invasive Esophagectomy Replace Open Esophagectomy for Esophageal Cancer? Latest Analysis of 24,233 Esophagectomies From the Japanese National Clinical Database.
PubMed 文献 · Ann Surg · 2020-01-01

该研究基于日本国家临床数据库2012至2016年24,233例食管切除术,排除临床T4/M1期、急诊、二期手术及R2切除后,采用广义估计方程逻辑回归分析术前治疗与手术方式对短期结局的影响。结果显示,无论术前治疗类型如何,微创食管切除术在多数术后并发症和手术相关死亡率上优于或等同于开放食管切除术,手术相关死亡率分别为1.7%和2.4%(P<0.001)。结论提示从短期结局角度,微创食管切除术可在多种情况下替代开放食管切除术。

要点

  • 微创食管切除术在多数术后并发症和手术相关死亡率上优于或等同于开放手术。
  • 无术前治疗患者中,微创组肺部并发症、 prolonged ventilation≥48小时、非计划插管、手术部位感染和脓毒症显著更少。
  • 无术前治疗患者中,微创组30天内再手术更常见。

核心结论

  • 从短期结局角度看,微创食管切除术可在多种情况下替代开放食管切除术。

研究设计与样本

  • 回顾性分析日本国家临床数据库2012至2016年24,233例食管癌食管切除术,排除临床T4/M1期、急诊、二期手术及R2切除,采用广义估计方程逻辑回归分析。

主要发现

  • 无论术前治疗类型如何,微创食管切除术在多数术后并发症和手术相关死亡率上优于或等同于开放食管切除术。
  • 无术前治疗患者中,微创食管切除术与任何肺部并发症、 prolonged ventilation≥48小时、非计划插管、手术部位感染和脓毒症发生率显著更低相关。
  • 无术前治疗患者中,微创食管切除术后30天内再手术更常见。
  • 微创和开放食管切除术的总手术相关死亡率分别为1.7%和2.4%(P<0.001)。
  • 高龄、低术前ADL、ASA≥3、需胰岛素糖尿病、COPD、充血性心衰、肌酐≥1.2 mg/dL和低医院病例量为手术相关死亡独立危险因素。

临床怎么用

  • 在符合条件的食管癌患者中,微创食管切除术可作为开放食管切除术的替代选择,尤其关注无术前治疗患者再手术风险。
  • 术前应评估高龄、ADL、ASA分级、糖尿病、COPD、心衰、肌酐及医院病例量等手术相关死亡危险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We aimed to elucidate whether minimally invasive esophagectomy (MIE) can be safely performed by reviewing the Japanese National Clinical Database. SUMMARY OF BACKGROUND DATA: MIE is being increasingly adopted, even for advanced esophageal cancer that requires various preoperative treatments. However, the superiority of MIE's short-term outcomes compared with those of open esophagectomy (OE) has not been definitively established in general clinical practice. METHODS: This study included 24,233 esophagectomies for esophageal cancer conducted between 2012 and 2016. Esophagectomy for clinical T4 and M1 stages, urgent esophagectomy, 2-stage esophagectomy, and R2 resection were excluded. The effects of preoperative treatment and surgery on short-term outcomes were analyzed using generalized estimating equations logistic regression analysis. RESULTS: MIE was superior or equivalent to OE in terms of the incidence of most postoperative morbidities and surgery-related mortality, regardless of the type of preoperative treatment. Notably, MIE performed with no preoperative treatment was associated with significantly less incidence of any pulmonary morbidities, prolonged ventilation ≥48 hours, unplanned intubation, surgical site infection, and sepsis. However, reoperation within 30 days in patients with no preoperative treatment was frequently observed after MIE. The total surgery-related mortality rates of MIE and OE were 1.7% and 2.4%, respectively (P < 0.001). Increasing age, low preoperative activities of daily living, American Society of Anesthesiologists physical status ≥3, diabetes mellitus requiring insulin use, chronic obstructive pulmonary disease, congestive heart failure, creatinine ≥1.2 mg/dL, and lower hospital case volume were identified as independent risk factors for surgery-related mortality. CONCLUSIONS: The results suggest that MIE can replace OE in various situations from the perspective of short-term outcome.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Yoshida N, Yamamoto H, Baba H, et al. Can Minimally Invasive Esophagectomy Replace Open Esophagectomy for Esophageal Cancer? Latest Analysis of 24,233 Esophagectomies From the Japanese National Clinical Database. Ann Surg. 2020. PMID: 30720501. doi:10.1097/SLA.0000000000003222

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。